tiprankstipranks
Evolent Health price target lowered to $41 from $44 at Canaccord
PremiumThe FlyEvolent Health price target lowered to $41 from $44 at Canaccord
2M ago
Evolent Health price target lowered to $34 from $38 at JMP Securities
PremiumThe Fly
Evolent Health price target lowered to $34 from $38 at JMP Securities
2M ago
Evolent Health sees 2024 revenue $2.56B-$2.60B, consensus $2.47B
PremiumThe Fly
Evolent Health sees 2024 revenue $2.56B-$2.60B, consensus $2.47B
2M ago
Evolent Health initiated with a Buy at Citi
PremiumThe FlyEvolent Health initiated with a Buy at Citi
3M ago
Evolent Health price target lowered to $44 from $45 at Canaccord
PremiumThe Fly
Evolent Health price target lowered to $44 from $45 at Canaccord
4M ago
GoodRx upgraded, Fisker downgraded: Wall Street’s top analyst calls
PremiumThe Fly
GoodRx upgraded, Fisker downgraded: Wall Street’s top analyst calls
5M ago
Evolent Health price target raised to $38 from $37 at JMP Securities
PremiumThe FlyEvolent Health price target raised to $38 from $37 at JMP Securities
5M ago
Evolent Announces Fourth Quarter and Full Year 2023 Results
PremiumPress Releases
Evolent Announces Fourth Quarter and Full Year 2023 Results
5M ago
Evolent Health sees FY24 revenue $2.4B-$2.5B, consensus $2.32B
PremiumThe Fly
Evolent Health sees FY24 revenue $2.4B-$2.5B, consensus $2.32B
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100